Literature DB >> 8617984

Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase 65 and are somatically mutated.

A M Madec1, F Rousset, S Ho, F Robert, C Thivolet, J Orgiazzi, S Lebecque.   

Abstract

The selective destruction by an autoimmune process of the beta cells in the pancreas is the hallmark of the type 1 insulin-dependent diabetes mellitus. What triggers islet cell-specific autoreactive T and B cells, however, remains unclear. Identification of the targets of the anti-islet cell autoantibodies frequently found in insulin-dependent diabetes mellitus patients and analysis of their sequences should provide some insights into the nature of this disease. We have combined EBV transformation with CD40 activation of peripheral B cells from one patient with insulin-dependent diabetes mellitus to isolate four B cell clones that secrete islet cell-specific autoantibodies, These four human monoclonal autoantibodies are of the IgG1 isotype, and they each recognize a different epitope of the glutamic acid decarboxylase enzyme. Analysis of their variable gene sequences shows that, while clonally unrelated, three of the four human monoclonal autoantibodies use a member of the VH4 family, and two have rearranged the same delta light chain variable gene. The IgG1 isotype of the four autoantibodies as well as the presence of somatic mutations in both heavy and light chain genes provide concrete evidence for their derivation by a T cell-dependent immune response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617984

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

Authors:  Esther Ganelin-Cohen; Dalit Modan-Moses; Rina Hemi; Hannah Kanety; Bruria Ben-Zeev; Christiane S Hampe
Journal:  Pediatr Diabetes       Date:  2015-12-29       Impact factor: 4.866

2.  Reduced display of conformational epitopes in the N-terminal truncated GAD65 isoform: relevance for people with stiff person syndrome or DQ8/8-positive Type 1 diabetes mellitus.

Authors:  C S Hampe; J R Radtke; A Wester; A Carlsson; E Cedervall; B Jönsson; S A Ivarsson; H Elding Larsson; K Larsson; B Lindberg; J Neiderud; O Rolandsson; Å Lernmark
Journal:  Diabet Med       Date:  2018-12-28       Impact factor: 4.359

3.  Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.

Authors:  M Schlosser; J P Banga; A M Madec; K A Binder; M Strebelow; I Rjasanowski; R Wassmuth; L K Gilliam; D Luo; C S Hampe
Journal:  Diabetologia       Date:  2005-04-16       Impact factor: 10.122

4.  T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes.

Authors:  F Rharbaoui; A Mayer; C Granier; M Bouanani; C Thivolet; B Pau; J Orgiazzi; A M Madec
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

5.  The MHC class II cofactor HLA-DM interacts with Ig in B cells.

Authors:  Henriette Macmillan; Michael J Strohman; Sashi Ayyangar; Wei Jiang; Narendiran Rajasekaran; Armin Spura; Ann J Hessell; Anne-Marie Madec; Elizabeth D Mellins
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

6.  Autoantibody epitopes to the smaller isoform of glutamate decarboxylase do not differ in Swedish and Japanese type 1 diabetes patients and may be associated with high-risk human leucocyte antigen class II alleles.

Authors:  T Maruyama; S Oak; T R Hall; J P Banga; E Ortqvist; R A Ettinger; J Endl; C S Hampe
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

7.  Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.

Authors:  Marta Rizzi; Rolf Knoth; Christiane S Hampe; Peter Lorenz; Marie-Lise Gougeon; Brigitte Lemercier; Nils Venhoff; Francesca Ferrera; Ulrich Salzer; Hans-Jürgen Thiesen; Hans-Hartmut Peter; Ulrich A Walker; Hermann Eibel
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

8.  Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.

Authors:  C S Hampe; T R Hall; A Agren; O Rolandsson
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

9.  Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient.

Authors:  J P Banga; J K Moore; N Duhindan; A M Madec; P M van Endert; J Orgiazzi; J Endl
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

10.  DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes.

Authors:  N Bansal; C S Hampe; L Rodriguez; E O'Brian Smith; J Kushner; A Balasubramanyam; M J Redondo
Journal:  Diabet Med       Date:  2016-02-12       Impact factor: 4.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.